🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective open-label, uncontrolled, single-blind, pilot clinica...
Status
Completed
Location
University of Alberta
Start Date
2014-10
Trial ID
NCT02774239
Treatments Being Tested
To examine the prevalence of humoral immunodeficiency in patients with Chro...
Status
Unknown
Location
Rochester Regional Health Ctr for Clinical Research - Alexander Park
Start Date
2023-06-01
Trial ID
NCT05764993
Treatments Being Tested
The objective of this study is to assess the efficacy, safety, tolerability...
Status
Completed
Location
Study site
Start Date
2010-09
Trial ID
NCT01199705
Treatments Being Tested
The purpose of this study is to determine whether Hizentra is a safe and ef...
Status
Completed
Location
Phoenix Neurological Associates
Start Date
2015-05
Trial ID
NCT02100969
Treatments Being Tested
This multicenter, open-label, parallel-arm, non-randomized study is designe...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2017-02-01
Trial ID
NCT03033745
Treatments Being Tested
The objective of this study is to assess the efficacy, tolerability, safety...
Status
Completed
Location
Study site
Start Date
2007-09
Trial ID
NCT00542997
Treatments Being Tested
This is a prospective, phase 3, multicenter, double-blind, randomized place...
Status
Terminated
Location
University of Alabama Hospital at Birmingham
Start Date
2024-08-28
Trial ID
NCT06524739
This study is a retrospective database study in Japan to evaluate the safet...
Status
Recruiting
Location
Takeda selected site
Start Date
2025-02-17
Trial ID
NCT06565078
Treatments Being Tested
This study will provide insights on the infusion parameters, dosing, and ex...
Status
Completed
Location
University of McMaster
Start Date
2018-09-24
Trial ID
NCT03716700
Treatments Being Tested
The main goal of the study is to find out whether XEMBIFY, given once a wee...
Status
Recruiting
Location
GC2402 Study Site 104
Start Date
2026-04-02
Trial ID
NCT07540221